GlassScriptPhysician profile
Vimal A Reddy
NPI 1962470617
$6,260.35
in general payments reported to CMS, 2019-2025
42 companies · $309 in 2025
The $309 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,515 · 2020: $524 · 2021: $288 · 2022: $132 · 2023: $223 · 2024: $269 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $801.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $801.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Team 1, LLC | $1,310.11 | 2019 | |
| Arthrex, INC. | $1,074.00 | 2019 | |
| Stryker Corporation | $1,002.27 | 2019-2025 | Prostep Mica, Prostep |
| Wright Medical Technology, INC. | $549.19 | 2019-2020 | |
| Horizon Therapeutics Plc | $540.15 | 2019-2021 | |
| Crossroads Extremity Systems, LLC | $252.85 | 2019 | |
| Smith+Nephew, INC. | $161.64 | 2019-2025 | Grafix Pl, Stravix, Regranex |
| Heron Therapeutics, INC. | $116.34 | 2021 | |
| Sebela Pharmaceuticals INC. | $114.41 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $105.28 | 2024-2025 | Nuzyra |
| Angiodynamics, INC. | $85.87 | 2019-2025 | Venacure 1470 Pro |
| Organogenesis INC. | $62.24 | 2020-2025 | Affinity |
| Urgo Medical North America, LLC | $59.35 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Zyla Life Sciences, INC. | $59.07 | 2019-2020 | |
| Progenacare Global, LLC | $55.26 | 2023-2024 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $54.42 | 2022-2024 | Intellis Adaptivestim |
| Bioventus LLC | $51.69 | 2019-2023 | Exogen Ultrasound Bone Healing System |
| Bard Peripheral Vascular, INC. | $49.80 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $41.36 | 2019-2024 | Exparel, Iovera |
| Acera Surgical, INC. | $38.84 | 2023-2024 | Restrata Wound Matrix |
| Sandoz INC. | $38.65 | 2019 | |
| Access Pro Medical, LLC | $33.78 | 2023 | Matriderm |
| Depuy Synthes Sales INC. | $33.06 | 2021 | |
| Averitas Pharma INC. | $30.03 | 2023 | Qutenza |
| Zimvie INC. | $29.69 | 2022-2023 | |
| Next Science LLC | $25.00 | 2024 | Blastx, Xperience, Surgx |
| Osiris Therapeutics INC. | $24.08 | 2019 | |
| Biocomposites INC | $23.93 | 2024 | |
| Misonix INC | $23.75 | 2020 | |
| Djo, LLC | $23.45 | 2021 | |
| Nabriva Therapeutics, Plc | $22.46 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $19.63 | 2025 | Cabtreo |
| Tei Medical INC. | $17.03 | 2019 | |
| Amgen INC. | $16.72 | 2025 | Krystexxa |
| Avita Medical Americas, LLC | $16.65 | 2024 | |
| Melinta Therapeutics, LLC | $16.11 | 2019 | |
| Merck Sharp & Dohme LLC | $16.05 | 2019 | |
| Embody, INC. | $15.75 | 2021 | |
| Acell, INC. | $14.69 | 2019 | |
| Reprise Biomedical, INC. | $13.08 | 2022 | |
| Abbvie INC. | $12.33 | 2021 | |
| Advanced Oxygen Therapy INC. | $10.29 | 2024 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vimal Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.